Patients with Parkinson disease present high ambulatory blood pressure variability

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorKANEGUSUKU, Helcio
dc.contributor.authorSILVA-BATISTA, Carla
dc.contributor.authorPECANHA, Tiago
dc.contributor.authorSILVA-JUNIOR, Natan
dc.contributor.authorQUEIROZ, Andreia
dc.contributor.authorCOSTA, Luiz
dc.contributor.authorMELLO, Marco
dc.contributor.authorPIEMONTE, Maria
dc.contributor.authorUGRINOWITSCH, Carlos
dc.contributor.authorFORJAZ, Claudia
dc.date.accessioned2017-10-24T13:17:43Z
dc.date.available2017-10-24T13:17:43Z
dc.date.issued2017
dc.description.abstractPatients with Parkinson disease (PD) present blunted nocturnal blood pressure fall and similar ambulatory blood pressure variability (ABPV) measured by standard deviation (SD) and coefficient of variation (CV) compared with healthy subjects. However, these classical indices of ABPV have limited validity in individuals with circadian blood pressure alterations. New indices, such as the average of daytime and night-time standard deviation weighted by the duration of the daytime and night-time intervals (SDdn) and the average real variability (ARV), remove the influence of the daytime and the night-time periods on ABPV. This study assessed ABPV by SDdn and ARV in PD. Twenty-one patients with PD (11 men, 66 +/- 2years, stages 2-3 of modified Hoehn & Yahr) and 21 matched controls without Parkinson disease (9 men, 64 +/- 1years old) underwent blood pressure monitoring for 24h. ABPV was analysed by 24h, daytime and night-time SD and CV, and by the SDdn and ARV. Systolic/diastolic 24-h and night-time SD and CV were similar between the patients with PD and the controls. The patients with PD presented higher daytime systolic/diastolic CV and SD than the controls (10<bold></bold>4 +/- 0<bold></bold>9/12<bold></bold>3 +/- 0<bold></bold>8 versus 7<bold></bold>0 +/- 0<bold></bold>3/9<bold></bold>9 +/- 0<bold></bold>5%, P<0<bold></bold>05; 12<bold></bold>6 +/- 1<bold></bold>0/9<bold></bold>1 +/- 0<bold></bold>5 versus 8<bold></bold>6 +/- 0<bold></bold>4/7<bold></bold>5 +/- 0<bold></bold>3mmHg, P<0<bold></bold>05, respectively) as well as higher systolic/diastolic SDdn (10<bold></bold>9 +/- 0<bold></bold>8/8<bold></bold>2 +/- 0<bold></bold>5 versus 8<bold></bold>2 +/- 0<bold></bold>3/7<bold></bold>1 +/- 0<bold></bold>2mmHg, P<0<bold></bold>05, respectively) and ARV (8<bold></bold>8 +/- 0<bold></bold>6/6<bold></bold>9 +/- 0<bold></bold>3 versus 7<bold></bold>2 +/- 0<bold></bold>2/6<bold></bold>0 +/- 0<bold></bold>2mmHg, P<0<bold></bold>05, respectively). In conclusion, patients with PD have higher ABPV than control subjects as assessed by SDd, CVd, SDdn and AVR.
dc.description.indexMEDLINE
dc.description.sponsorshipCNPQ
dc.description.sponsorshipCAPES
dc.identifier.citationCLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING, v.37, n.5, p.530-535, 2017
dc.identifier.doi10.1111/cpf.12338
dc.identifier.eissn1475-097X
dc.identifier.issn1475-0961
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/21886
dc.language.isoeng
dc.publisherWILEY
dc.relation.ispartofClinical Physiology and Functional Imaging
dc.rightsrestrictedAccess
dc.rights.holderCopyright WILEY
dc.subjectambulatory blood pressure
dc.subjectcircadian blood pressure
dc.subjectcircadian variability
dc.subjectnocturnal blood pressure fall
dc.subjectParkinsonism
dc.subject.otherhypertensive patients
dc.subject.otherprognostic value
dc.subject.otherfall
dc.subject.otherassociation
dc.subject.otherpopulation
dc.subject.othermortality
dc.subject.otherdiagnosis
dc.subject.otherscale
dc.subject.wosPhysiology
dc.titlePatients with Parkinson disease present high ambulatory blood pressure variability
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.author.externalKANEGUSUKU, Helcio:Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil
hcfmusp.author.externalSILVA-BATISTA, Carla:Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil
hcfmusp.author.externalPECANHA, Tiago:Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil
hcfmusp.author.externalSILVA-JUNIOR, Natan:Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil
hcfmusp.author.externalQUEIROZ, Andreia:Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil
hcfmusp.author.externalCOSTA, Luiz:Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil
hcfmusp.author.externalMELLO, Marco:Univ Fed Minas Gerais, Sch Phys Educ, Sao Paulo, Brazil
hcfmusp.author.externalUGRINOWITSCH, Carlos:Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil
hcfmusp.author.externalFORJAZ, Claudia:Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil
hcfmusp.citation.scopus20
hcfmusp.contributor.author-fmusphcMARIA ELISA PIMENTEL PIEMONTE
hcfmusp.description.beginpage530
hcfmusp.description.endpage535
hcfmusp.description.issue5
hcfmusp.description.volume37
hcfmusp.origemWOS
hcfmusp.origem.pubmed28776928
hcfmusp.origem.scopus2-s2.0-84954150527
hcfmusp.origem.wosWOS:000407261100010
hcfmusp.publisher.cityHOBOKEN
hcfmusp.publisher.countryUSA
hcfmusp.relation.referenceAerts MB, 2009, PARKINSONISM RELAT D, V15, P712, DOI 10.1016/j.parkreldis.2009.03.001
hcfmusp.relation.referenceAsayama K, 2014, CLIN EXP PHARMACOL P, V41, P1, DOI 10.1111/1440-1681.12091
hcfmusp.relation.referenceBilo G, 2007, J HYPERTENS, V25, P2058
hcfmusp.relation.referenceBouhaddi M, 2004, AUTON NEUROSCI-BASIC, V116, P30, DOI 10.1016/j.autneu.2004.06.009
hcfmusp.relation.referenceCarthy ER, 2013, ANN MED SURG LOND, V3, P2, DOI 10.1016/J.AMSU.2013.11.002
hcfmusp.relation.referenceFRATTOLA A, 1993, J HYPERTENS, V11, P1133, DOI 10.1097/00004872-199310000-00019
hcfmusp.relation.referenceGAI WP, 1993, ANN NEUROL, V33, P357, DOI 10.1002/ana.410330405
hcfmusp.relation.referenceGoetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213
hcfmusp.relation.referenceGoetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340
hcfmusp.relation.referenceHansen TW, 2005, HYPERTENSION, V45, P499, DOI 10.1161/01.HYP.0000160402.39597.3b
hcfmusp.relation.referenceHUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181
hcfmusp.relation.referenceJankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045
hcfmusp.relation.referenceJellinger KA, 2011, J NEUROL SCI, V310, P107, DOI 10.1016/j.jns.2011.04.012
hcfmusp.relation.referenceKario K, 1996, HYPERTENSION, V27, P130
hcfmusp.relation.referenceMena L, 2005, J HYPERTENS, V23, P505, DOI 10.1097/01.hjh.0000160205.81652.5a
hcfmusp.relation.referenceMoreira LFP, 2010, ARQ BRAS CARDIOL, V95, P1, DOI 10.1590/S0066-782X2010001100001
hcfmusp.relation.referenceO'Brien E, 2005, J HYPERTENS, V23, P697, DOI 10.1097/01.hjh.0000163132.84890.c4
hcfmusp.relation.referenceOh YS, 2014, J NEUROL SCI, V344, P186, DOI 10.1016/j.jns.2014.06.056
hcfmusp.relation.referenceOh YS, 2013, CHRONOBIOL INT, V30, P811, DOI 10.3109/07420528.2013.766618
hcfmusp.relation.referenceOhkubo T, 1997, AM J HYPERTENS, V10, P1201, DOI 10.1016/S0895-7061(97)00274-4
hcfmusp.relation.referenceOrimo S, 2008, BRAIN, V131, P642, DOI 10.1093/brain/awm302
hcfmusp.relation.referencePierdomenico SD, 2009, AM J HYPERTENS, V22, P842, DOI 10.1038/ajh.2009.103
hcfmusp.relation.referencePlaschke M, 1998, J HYPERTENS, V16, P1433, DOI 10.1097/00004872-199816100-00006
hcfmusp.relation.referencePursiainen V, 2007, ACTA NEUROL SCAND, V115, P104, DOI 10.1111/j.1600-0404.2006.00742.x
hcfmusp.relation.referenceRock W, 2014, J AM SOC HYPERTENS, V8, P498, DOI 10.1016/j.jash.2014.03.331
hcfmusp.relation.referenceSchmidt C, 2009, MOVEMENT DISORD, V24, P2136, DOI 10.1002/mds.22767
hcfmusp.relation.referenceSenard J M, 1992, Clin Auton Res, V2, P99, DOI 10.1007/BF01819664
hcfmusp.relation.referenceStaessen JA, 1999, JAMA-J AM MED ASSOC, V282, P539, DOI 10.1001/jama.282.6.539
hcfmusp.relation.referenceStuebner E, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00049
hcfmusp.relation.referenceSzili-Torok T, 2001, NEUROBIOL AGING, V22, P435, DOI 10.1016/S0197-4580(01)00210-X
hcfmusp.scopus.lastupdate2024-04-18
relation.isAuthorOfPublication52fbf6b3-40e9-464f-8ef4-f5795094d1e7
relation.isAuthorOfPublication.latestForDiscovery52fbf6b3-40e9-464f-8ef4-f5795094d1e7
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_KANEGUSUKU_Patients_with_Parkinson_disease_present_high_ambulatory_blood_2017.PDF
Tamanho:
76.07 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)